Imaging the Future
Imaging the Future

Society of Interventional Radiology Advances Global Definition of Specialty, Benefits Patients
A First: 41 International Societies Join SIR in Supporting Statement That Stresses Interventional Radiology's Importance in Medical Care for Patients, Outlines Identity and Scope of IR Practices Worldwide FAIRFAX, Va., July 7 /PRNewswire-USNewswire/ -- The Society of Interventional Radiology, with the support of 41 international societies representing 10,000 interventional radiology doctors, has issued the first global statement defining interventional radiology—one designed to benefit medical treatment for individuals.

Announcing: Intrinsic Imaging : Radiology Experts Launch Novel Medical Imaging CRO for Clinical Trials
Leading clinical trial professionals have launched Intrinsic Imaging LLC. Located in San Antonio, Intrinsic is a leading bio/pharmaceutical services organization providing complete image management and radiological review services to global pharmaceutical, biotechnology and medical device organizations. With its team of more than sixty sub-specialized, board-certified radiologists, and through its use of advanced medical imaging technology, Intrinsic’s experienced clinical trial team provides pharmaceutical and biotech sponsors with comprehensive imaging core lab services across all therapeutic areas

Texas Instruments' medical imaging software toolkit offers new image processing algorithms, shortened development time for OEMs designing on C64x+ DSP
DALLAS, June 9 /PRNewswire/ -- Texas Instruments Incorporated (TI) (NYSE: TXN) today announced the availability of its version 2.0 medical imaging software toolkit (STK), an updated and expanded collection of imaging algorithms optimized for TI's TMS320C64x+â„¢ digital signal processors (DSPs).

VisEn Announces New ProSense® 750 FAST and Neutrophil Elastase™ 680 FAST Fluorescence Molecular Imaging Agents at European Molecular Imaging Meetin
BEDFORD, Mass. and WARSAW, Poland, May 26 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the commercial launch of two new imaging agents -- ProSense® 750 FAST for expanded versatility in imaging cathepsin activity, and Neutrophil Elastaseâ„¢ 680 FAST, for imaging of inflammatory elastase activity associated with disease progression and therapeutic response.

Ziehm Imaging and Pie Medical Imaging Announce Cooperation
NUREMBERG, Germany, May 25, 2010 /PRNewswire/ -- Ziehm Imaging and Pie Medical Imaging BV have joined forces to make the CAAS quantification software available on mobile C-arms dedicated for cardiovascular procedures. This capability is the result of Ziehm Imaging's strategic partnership with Pie Medical Imaging BV (PMI, Maastricht, the Netherlands), a leading developer of quantitative analysis software for cardiology and radiology.



Privacy Policy | Copyright/Trademark Notification